February 16, 2022 – Cardiology is an inherently data-dependent and data-driven practice. Patient medical history records, images, test results, and more go into every diagnosis and treatment decision. However, most organizations don’t take advantage of structured reporting, most cardiovascular information systems (CVIS) cannot effectively mine the wealth of data from a facility’s cardiology department. There is no debate on how crucial structured reporting is.

February 16, 2022 – Inari Medical, Inc. has announced that the first patient has been enrolled in PEERLESS, a prospective, randomized controlled trial comparing the outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the FlowTriever system versus

February 16, 2022 – The Heart Institute at Children’s Hospital Colorado (Children’s Colorado) has performed its 500th pediatric heart transplant, a milestone that only a few centers across the country have reached.

February 16, 2022 – A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart arrhythmia diagnosis in clinical practice — has debuted at UC San Diego Health.

February 16, 2022 – The Centers for Disease Control and Prevention estimate that someone in the United States has a stroke every 40 seconds. Hundreds of thousands of people each year are living with the long-term impacts caused by strokes — including partial paralysis, cognitive difficulties and persistent pain — with no consistently effective treatment options for improving their neurological conditions. 

February 16, 2022 – A revolutionary pacemaker that re-establishes the heart’s naturally irregular beat is set to be trialed in New Zealand heart patients this year, following successful animal trials. “Currently, all pacemakers pace the heart metronomically, which means a very steady, even pace.

February 15, 2022 — American Heart Association CEO Nancy Brown issued the following statement in response to the Senate confirmation of Robert M. Califf, M.D., as commissioner of the Food and Drug Administration (FDA):

February 15, 2022 – More than $625,000 in research grants devoted to congenital heart defects (CHD) were awarded today by the American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives, and The Children’s Heart Foundation, the nation’s leading organization dedicated to funding CHD research.

Subscribe Now